Month: September 2024

GRANTS, NEW MEXICO, Sept. 19, 2024 (GLOBE NEWSWIRE) — Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”), today announced that trading of its shares have been suspended from the Nasdaq Stock Exchange (“Nasdaq”) after Nasdaq cancelled the scheduled September 26, 2024 delist appeal hearing. While this development represents a change in the Company’s public trading status, Bright Green remains committed to pursuing its strategic goals and delivering value to its shareholders. The Company filed its Proxy Statement and will proceed with its scheduled annual meeting on November 15, 2024, during which shareholders will discuss key issues, including the potential for a reverse stock split aimed at enhancing shareholder value and positioning the Company for future success. In addition to these efforts, the Company...

GRAND CAYMAN, Cayman Islands, Sept. 19, 2024 (GLOBE NEWSWIRE) — SRIVARU Holding Limited (Nasdaq: SVMH, SVMHW) (“SRIVARU” or the “Company”), a leading innovator in the electric motorcycle market, today announced that it has received a favorable decision from the Nasdaq Hearings Panel (the “Panel”). The Panel’s decision grants the Company’s request for continued listing on Nasdaq, which we believe will provide SRIVARU the necessary time to implement its plan to regain compliance with Nasdaq’s listing requirements. Following the Company’s hearing on September 5, 2024, the Panel has stipulated specific conditions for continued listing. SRIVARU must fulfill the below requirements by November 14, 2024:Submitting a public filing and financial statements that confirm the Company meets Nasdaq’s shareholder...

Regulated InformationIssy-les-Moulineaux, September 19, 2024 DISCLOSURE OF TRANSACTIONS IN OWN SHARES CARRIED OUT FROM SEPTEMBER 16 TO SEPTEMBER 17, 2024 Sodexo purchased treasury shares, outside of its liquidity contract, within the framework of its share buyback program as authorized by the Shareholders’ Meeting held on December 15, 2023. These shares have been acquired to honor obligations related to free shares award plans. Information on these transactions are the following:Trading date LEI ISIN Volume(in number of shares) Weighted average purchase price (in euros) Market           16/09/2024 969500AGKR3PRJG4WD05 FR0000121220 12,472 77.9203 XPAR16/09/2024 969500AGKR3PRJG4WD05 FR0000121220 11,690 78.0104 CEUX16/09/2024 969500AGKR3PRJG4WD05 FR0000121220 2,000 77.9691 TQEX16/09/2024 969500AGKR3PRJG4WD05 FR0000121220 1,774 77.899 AQEU17/09/2024 969500AGKR3PRJG4WD05 FR0000121220 9,519 78.543 XPAR17/09/2024 969500AGKR3PRJG4WD05 FR0000121220 5,700 78.5788 CEUX17/09/2024 969500AGKR3PRJG4WD05 FR0000121220 500 78.6348 TQEX17/09/2024 969500AGKR3PRJG4WD05 FR0000121220 500 78.6501 AQEU                          Total 44,155 78.1811             Detailed...

TORONTO, Ontario, Sept. 19, 2024 (GLOBE NEWSWIRE) — Titan Medical Inc. (“Titan”) (TSX: TMD; OTC: TMDIF) is pleased to announce that a second independent proxy advisor, Glass Lewis has recommended that their clients to vote their shares FOR the proposed amalgamation with Conavi Medical Inc. (the “Amalgamation”) at the annual general and special meeting of Titan to be held on September 30, 2024 (the “Meeting”). Glass Lewis is the second leading independent proxy advisory firm to recommend shareholders vote “FOR” the Amalgamation, following the previously announced recommendation from Institutional Shareholder Services (“ISS”). In reaching its recommendation that Shareholders vote FOR the Amalgamation Glass Lewis stated in their report: “Placed in context with contemporaneous operational and financial obstacles discussed in the Company’s...